CorMedix (CRMD) Tops Q2 EPS by 6c; Offers Guidance
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 11/4/2026
- Wall Street ends higher after Democrats win Congress; data center stocks tumble
- What the Democratic sweep in the midterms means for markets
- SpaceX, Tesla slide as election risks mount, Morgan Stanley turns bullish
- CVS Health plans to split into two public companies by 2028
- AI sector outlook darkens as Democrat wins threaten $900B capex cycle
| CORMEDIX, Inc. (NASDAQ: CRMD) | Delayed: 5.66 +0.10 (1.80%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $5.56 | 52 Week High | $4.54 | |||
| Open | $5.71 | 52 Week Low | $1.15 | |||
| Day High | $5.79 | P/E | N/A | |||
| Day Low | $5.58 | EPS | $-0.55 | |||
| Volume | 1,491,177 | |||||
